The inventive medicinal agent for treating bird flu comprises an antibody form which is activated and potentiated to alpha, beta or gamma bird interferon and which is obtainable by repeatedly and consecutively diluting and exposing it to an external action according to homeopathic technology providing an ultra-small antibody dose.
